These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 790943)

  • 41. [Therapy of gastric and duodenal ulcer. Conservative treatment of the ulcer diseases].
    Demling L
    Chirurg; 1968 Nov; 39(11):485-8. PubMed ID: 5704014
    [No Abstract]   [Full Text] [Related]  

  • 42. [Secretin versus somatostatin in acute hemorrhage of gastroduodenal ulcers and erosions: a randomized trial].
    Wagner PK; Rothmund M; Grönniger J
    Klin Wochenschr; 1983 Mar; 61(6):285-9. PubMed ID: 6408298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antacids and drug trials for duodenal ulcer.
    Prizont R; Fredd SB
    Lancet; 1989 Apr; 1(8643):896. PubMed ID: 2564965
    [No Abstract]   [Full Text] [Related]  

  • 44. Methyl-prostaglandin E2 analogues for healing of gastro-duodenal ulcers.
    Rybicka J; Gibiński K
    Scand J Gastroenterol; 1978; 13(2):155-9. PubMed ID: 345414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vivo evaluation of the effect of antacids and H2 receptor blockaders on the intragastric pH in gastric and duodenal ulcer].
    Waserstein M; Dacoll C; Cohen H; Gamboa L; Brener A; de Mizrahi JB; Sempol D; Neumark A; Nieto F; Tenzer S
    Acta Gastroenterol Latinoam; 1985; 15(4):243-55. PubMed ID: 2878555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of 2 antacids with different acid binding capacity in low dosage in the treatment of duodenal ulcer].
    Hüttemann W
    Med Klin (Munich); 1988 Jan; 83(1):12-6. PubMed ID: 3280957
    [No Abstract]   [Full Text] [Related]  

  • 49. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
    Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK
    Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A double-blind study with misoprostol in the treatment of active duodenal ulcer].
    Mazure PA; Cosen JN; Ciccia JE; Colombato LO; Luis A; Arguto JF; Boffi A
    Acta Gastroenterol Latinoam; 1985; 15(1):13-24. PubMed ID: 3937407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of secretin release in patients with duodenal ulcer.
    Bloom SR; Ward AS
    Br Med J; 1975 Jan; 1(5950):126-7. PubMed ID: 234267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients.
    Müller P; Simon B; Khalil H; Lühmann R; Leucht U; Schneider A
    Z Gastroenterol; 1992 Nov; 30(11):771-5. PubMed ID: 1471382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretin-induced histamine release in duodenal-ulcer patients.
    Baenkler HW; Mitznegg P; Domschke S; Wünsch E; Subramanian N; Domschke W; Bötticher R; Sprügel W; Demling L
    Lancet; 1977 Apr; 1(8018):928-9. PubMed ID: 67387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acid and endocrine responses to meals varying in pH in normal and duodenal ulcer subjects.
    Thompson JC; Swierczek JS
    Ann Surg; 1977 Oct; 186(4):541-48. PubMed ID: 907397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial.
    Bright-Asare P; Sontag SJ; Gould RJ; Brand DL; Roufail WM
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):63S-67S. PubMed ID: 3080291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose antacids versus ranitidine in the short-term treatment of patients with duodenal ulcer. Endoscopic and histologic placebo-controlled study.
    Mach T; Bogdał J
    Mater Med Pol; 1992; 24(3):201-4. PubMed ID: 1307655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers.
    Hoetzinger H
    Pharmatherapeutica; 1985; 4(3 Spec No):155-60. PubMed ID: 3903784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lattice structure antacids and antacid mixtures].
    Miederer SE; Schmidt C
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():130-5. PubMed ID: 3660893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.
    Kumar N; Vij JC; Karol A; Anand BS
    Gut; 1984 Nov; 25(11):1199-202. PubMed ID: 6389273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
    Gisbert JP; Boixeda D; de Rafael L; Alvarez Baleriola I; Martín de Argila C; García M; García Plaza A
    Rev Esp Enferm Dig; 1996 Mar; 88(3):179-84. PubMed ID: 8645510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.